Catherine Dunand

Biography

Catherine Dunand has held several executive posts in the pharmaceutical industry, among them, International Marketing Manager, Head of International Marketing, and Head of International Profit Centers. Working with companies such as Roussel Uclaf and Hoechst Marion Roussel (now parts of SANOFI), Dunand has also conducted several M&A assignments and reorganization projects. Following her work in the pharmaceutical industry, Dunand served as the CEO of several SMEs, leading two successive LBOs. For the last eight years, she has dedicated herself to consulting and non-executive assignments for growing SMEs, including family owned companies, listed companies and private equity funds. In addition, she holds minority stakes in several private equity investments. Following the sale of pharmaceutical company HRA, Dunand helped to found CEMAG INVEST, a family office investing in healthcare and B to B services. She currently serves as the company’s CEO. Catherine is graduated from Ecole Centrale de Lyon, Insead (MBA), Sciences Po/IFA – Institut Français des Administrateurs (Non-Executive Director certification).

Research Interest

Bioinformatics & Systems Biology